Rinta Ibuki - Concepedia

Concepedia

Author

Rinta Ibuki

Fujisawa City Hospital

Also Known As

R. Ibuki, Rinta IBUKI, Rinta Ibuki

28

Publications

1.1K

Citations

15

H-Index

38

Concepts

All Affiliations

Fujisawa City Hospital Kumamoto University Okayama University University of Kansas Mochida Pharmaceutical (Japan)

RI

About

Rinta Ibuki is an author at Fujisawa City Hospital specializing in pharmacology, medicine, and biomedical engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	300
2	Engineering	3	3	90
3	Allergy	2	2	35
4	Education	1	1	21
5	Biochemistry	1	1	134

Rinta Ibuki

×

15

Publications

1.1K

Citations

15

H-Index

	Year	Citations
Establishment of new preparation method for solid dispersion formulation of tacrolimus Kazunari Yamashita, Toshiomi Nakate, Kazuto Okimoto, International Journal of Pharmaceutics Biomedical EngineeringNew Preparation MethodPharmaceutical TechnologySolid Dispersion Formulation	2003	340
Tacrolimus is a class II low-solubility high-permeability drug: The effect of P-glycoprotein efflux on regional permeability of tacrolimus in rats Shigeki Tamura, Atsuo Ohike, Rinta Ibuki, Journal of Pharmaceutical Sciences Molecular PharmacologyBiochemistryMedicinePhysiologyP-glycoprotein Efflux	2002	134
Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): In vivo evaluation Nobuyuki Tanaka, Keiji Imai, Kazuto Okimoto, Journal of Controlled Release Pharmaceutical ScienceNovel Sustained-release SystemDisintegration-controlled Matrix TabletSolid Dispersion GranulesPharmaceutical Technology	2006	93
Dissolution mechanism and rate of solid dispersion particles of nilvadipine with hydroxypropylmethylcellulose Kazuto Okimoto, Masatoshi Miyake, Rinta Ibuki, International Journal of Pharmaceutics Solid Dispersion ParticlesPolymer SolutionDissolution MechanismMicroemulsionRheology	1997	91
Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine Nobuyuki Tanaka, Keiji Imai, Kazuto Okimoto, Journal of Controlled Release Pharmaceutical ScienceNovel Sustained-release SystemDisintegration-controlled Matrix TabletSolid Dispersion GranulesPharmaceutical Technology	2005	76
The Site-Specific Transport and Metabolism of Tacrolimus in Rat Small Intestine Shigeki Tamura, Yuji Tokunaga, Rinta Ibuki, Journal of Pharmacology and Experimental Therapeutics	2003	56
Applicability of (SBE)7m-β-CD in controlled-porosity osmotic pump tablets (OPTs) Kazuto Okimoto, Yuji Tokunaga, Rinta Ibuki, International Journal of Pharmaceutics Porous MembranePharmaceutical TechnologyDrug Delivery SystemsBiomedical EngineeringDrug Delivery System	2004	49
Factors affecting membrane-controlled drug release for an osmotic pump tablet (OPT) utilizing (SBE)7m-β-CD as both a solubilizer and osmotic agent Kazuto Okimoto, Atsuo Ohike, Rinta Ibuki, Journal of Controlled Release Osmotic AgentPharmaceutical ScienceMedicinePharmaceutical TechnologyOsmotic Pump Tablet	1999	45
Design and Evaluation of an Osmotic Pump Tablet (OPT) for Chlorpromazine Using (SBE)7m-β-CD Kazuto Okimoto, Atsuo Ohike, Rinta Ibuki, Pharmaceutical Research	1999	44
Development of a Novel Drug Release System, Time-Controlled Explosion System(TES). III. Relation between Lag Time and Membrane Thickness. Satoshi Ueda, Rinta Ibuki, Sumihisa Kimura, Chemical and Pharmaceutical Bulletin EngineeringMembrane ThicknessBiomedical EngineeringTime-controlled Explosion SystemChemical Engineering	1994	39

Page 1